Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Upcoming Meetings: Clinical Laboratory Improvement Advisory Committee

This article was originally published in The Gray Sheet

Executive Summary

Clinical Laboratory Improvement Advisory Committee: Scheduled to meet March 5-6 at the Centers for Disease Control and Prevention in Atlanta, according to a Feb. 14 Federal Register notice. The agenda for March 5 entails an orientation for new CLIAC members. On March 6, CDC will provide an update on the status of proposed rules for cytology, Accurate and Precise Technology, and waiver criteria, while the Health Care Financing Administration will provide an update on implementation of the Clinical Laboratory Improvement Amendments and FDA will offer a general update. Also slated are "presentations on the use of automated cytology instruments" and demonstrations of "computer-based cytology proficiency testing (PT) developed in cooperative agreement with CDC." For more information, contact CDC's John Ridderhof at 770/488-7660...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel